Clinical Trial Update: Study of Rebamipide Eye Drops to Treat Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 study of Rebamipide Eye Drops for Keratoconjunctivitis Sicca (dry eye) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Keratoconjunctivitis Sicca

Drugs mentioned

• Rebamipide Eye Drops (rebamipide)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Keratoconjunctivitis Sicca | Phase 3 | Status: COMPLETED